Further expands HeartSciences extensive patent portfolio
July 11, 2024
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company…
Read More
Medical device company R3 Vascular Inc., a developer of novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), has announced the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.
July 11, 2024
R3 Vascular Appoints Josh Smale as Vice President of Global Clinical and Scientific Affairs
July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for…
Read More
Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM).
July 10, 2024
Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic Groups
July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal…
Read More
the cardiology clinic of the future
By Stuart Long
July 10, 2024
Step Into the Cardiology Clinic of the Future: Bringing Virtual Cardiac Care Delivery and Virtual Telemetry to Life in Your Practice’s Clinical Workflows
In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular…
Read More
ProtheraCytes
July 10, 2024
CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes for the Treatment of Acute Myocardial Infarction
July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues,…
Read More
Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD)
July 10, 2024
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension
July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that…
Read More
Keith Churchwell, M.D., FAHA, has been named new volunteer president at the American Heart Association for fiscal year 2024-2025.
July 09, 2024
American Heart Association Announces New 2024-2025 National Volunteer Leaders
July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading…
Read More
Counties tend to be more rural and socioeconomically disadvantaged
July 09, 2024
Almost Half of US Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet…
Read More
The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY Endovascular Robotic Surgical System
July 09, 2024
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY…
Read More
Vivek Reddy, MD
July 08, 2024
Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation Patients
July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF…
Read More
July 08, 2024
Webinar on Optimizing Structural Heart Workflows to Take Place Next Week
On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows:…
Read More
During the American Heart Association Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2024 taking place in Chicago this week, two new, basic research studies in rodents (mice and rats) analyzed the impacts that alcohol may have on the heart.
July 05, 2024
New Research on Alcohol’s Impact on the Heart at American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024
July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS, …
Read More
Happy 4th from the DAIC team in Chicago
July 04, 2024
Happy 4th from the DAIC team
The DAIC team wishes you a safe and happy 4th of July!
Read More
Researchers call for monitoring of quality, outcomes in era of private equity ownership
July 03, 2024
Study: Private Equity Acquisitions in Cardiology on the Rise
July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94%…
Read More
Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in heart transplantation, heart failure, and other complex cardiac conditions
July 03, 2024
Cedars-Sinai Cardiologist Leads the American Society of Transplantation
July 3, 2024 — Jon Kobashigawa, MD, director of the Heart Transplant Program in the Department of Cardiology in the…
Read More
Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels
July 02, 2024
Biotronik Introduces Expanded Maximum Diameter Dimensions for Orsiro Mission DES
July 2, 2024 —  Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the…
Read More
Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels
July 02, 2024
FDA Issues Left Ventricular Assist System Monitor Correction: Abbott Issues Correction for HeartMate LVAS System Monitor due to Screen Issues that May Cause Unintentional Pump Stop
July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its…
Read More
List of DAIC's Top 10 articles for June
By Melinda Taschetta-Millane
July 02, 2024
DAIC's Top 10 for June
From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1. …
Read More
Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer
July 01, 2024
CVRx Announces Key Senior Leadership Team Hires
July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior…
Read More
The program aims to improve health outcomes, with a focus on increasing awareness of the symptoms and risks of hypertension
June 28, 2024
Expansion of AstraZeneca’s Flagship Health Equity Program Healthy Heart Africa
June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now